Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ticagrelor Administered as Standard Tablet or orodispersiblE foRmulation

NCT03822377 is registered in ClinicalTrials.gov with Azienda Ospedaliero Universitaria di Sassari as lead sponsor.

NCT NCT03822377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03822377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ticagrelor Administered as Standard Tablet or orodispersiblE foRmulation
Lead sponsor
Azienda Ospedaliero Universitaria di Sassari
Phase
Phase 3
Overall status
Completed
Start date
June 27, 2019
Completion date
August 31, 2020
Enrollment
130 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nstemi - non-st segment elevation mi, st elevation myocardial infarction